Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xuriden for hereditary orotic aciduria

Sep. 7, 2015

FDA approves Varubi for nausea and vomiting associated with cancer chemotherapy

Sep. 3, 2015

Kanuma becomes first approved treatment in E.U. for LAL-D

Sep. 1, 2015

ALK's house dust mite allergy immunotherapy approved in 11 European countries

Sep. 1, 2015

FDA approves Aptiom as monotherapy for partial-onset seizures

Aug. 31, 2015

Exelixis receives first regulatory approval of cobimetinib in Switzerland

Aug. 28, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease

Aug. 25, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026